文献速递贫血与红细胞疾病

升高的CDKN1A(P21)介导β-地中海贫血红系凋亡,但其缺失并不改善β-地中海贫血的红系生成

Elevated CDKN1A (P21) mediates β-thalassemia erythroid apoptosis, but its loss does not improve β-thalassemic erythropoiesis.
PubMed 文献 · Blood Adv · 2023-01-01

研究利用β-地中海贫血小鼠模型(Hbbth3/+)及患者来源红系前体细胞,发现FOXO3转录因子失调参与红系凋亡,其靶基因Cdkn1a(P21)在β-地中海贫血红系前体细胞中显著上调。双突变p21/Hbbth3/+小鼠红系凋亡和循环Epo减少,但无效红系成熟、髓外造血和脾肿大未改善。

要点

  • FOXO3失调参与β-地中海贫血红系凋亡,Foxo3缺失可减少凋亡并改善红细胞和血红蛋白生成。
  • Cdkn1a(P21)在β-地中海贫血小鼠和患者红系前体细胞中显著上调。
  • p21缺失减少红系凋亡和循环Epo,但不改善无效红系成熟、髓外造血和脾肿大。

核心结论

  • 控制β-地中海贫血红系细胞存活和分化的机制与无效红系生成解偶联,涉及包括FOXO3和P21的分子网络。
  • 这些研究为研究β-地中海贫血无效红系生成提供了新框架。

研究设计与样本

  • 研究使用β-地中海贫血小鼠模型(Hbbth3/+)及患者来源的红系前体细胞。
  • 构建了Foxo3-/-/Hbbth3/+和p21-/-/Hbbth3/+双突变小鼠进行体内研究。

主要发现

  • 在Foxo3-/-/Hbbth3/+小鼠中,红系凋亡显著减少,红系细胞成熟、红细胞和血红蛋白生成大幅改善,尽管双突变红系母细胞中活性氧升高。
  • Foxo3-/-/Hbbth3/+小鼠中网织红细胞升高和脾肿大持续存在,提示无效红系生成未解决。
  • Cdkn1a(P21)在β-地中海贫血小鼠和患者来源红系前体细胞中均显著上调。
  • p21/Hbbth3/+双突变小鼠出现胚胎致死,仅一部分小鼠存活至断奶。
  • 在成年存活p21-/-/Hbbth3/+小鼠中,红系凋亡和循环Epo较Hbbth3/+小鼠大幅减少,但无效红系细胞成熟、髓外造血和脾肿大未改变。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

β-thalassemias are common hemoglobinopathies due to mutations in the β-globin gene that lead to hemolytic anemias. Premature death of β-thalassemic erythroid precursors results in ineffective erythroid maturation, increased production of erythropoietin (EPO), expansion of erythroid progenitor compartment, extramedullary erythropoiesis, and splenomegaly. However, the molecular mechanism of erythroid apoptosis in β-thalassemia is not well understood. Using a mouse model of β-thalassemia (Hbbth3/+), we show that dysregulated expression of the FOXO3 transcription factor is implicated in β-thalassemia erythroid apoptosis. In Foxo3-/-/Hbbth3/+ mice, erythroid apoptosis is significantly reduced, whereas erythroid cell maturation, and red blood cell and hemoglobin production are substantially improved even with elevated reactive oxygen species in double-mutant erythroblasts. However, persistence of elevated reticulocytes and splenomegaly suggests that ineffective erythropoiesis is not resolved in Foxo3-/-/Hbbth3/+. We found the cell cycle inhibitor Cdkn1a (cyclin-dependent kinase inhibitor p21), a FOXO3 target gene, is markedly upregulated in both mouse and patient-derived β-thalassemic erythroid precursors. Double-mutant p21/Hbbth3/+ mice exhibited embryonic lethality with only a fraction of mice surviving to weaning. Notably, studies in adult mice displayed greatly reduced apoptosis and circulating Epo in erythroid compartments of surviving p21-/-/Hbbth3/+ mice relative to Hbbth3/+ mice, whereas ineffective erythroid cell maturation, extramedullary erythropoiesis, and splenomegaly were not modified. These combined results suggest that mechanisms that control β-thalassemic erythroid cell survival and differentiation are uncoupled from ineffective erythropoiesis and involve a molecular network including FOXO3 and P21. Overall, these studies provide a new framework for investigating ineffective erythropoiesis in β-thalassemia.

来源:Blood Adv,查看原文。版权归原作者所有。

引用

  1. Liang R, Lin M, Menon V, et al. Elevated CDKN1A (P21) mediates β-thalassemia erythroid apoptosis, but its loss does not improve β-thalassemic erythropoiesis. Blood Adv. 2023. PMID: 37672319. doi:10.1182/bloodadvances.2022007655

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。